Bioventus Cuts Outlook as Third-Quarter Sales Miss Expectations
Bioventus shares fell 11% to $11.75 in after-hours trading Monday after the company cut its outlook and reported third-quarter sales below analyst expectations. Shares closed down 1.3% at $13.15; they had risen 77% year to date through the close.
By Elias SchisgallShares of Bioventus fell after the company cut its outlook and reported sales in the third quarter that missed analyst expectations.The stock fell 11% to $11.75 in after-hours trading on Monday. Shares closed down 1.3% at $13.15 and had risen 77% year-to-date through the close.The…